Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Reinhard Kandera Insider Profile
4 Followers
Reinhard Kandera, CFO, Director at Hookipa Pharma, holds 43.09K shares in Hookipa Pharma (Ticker: HOOK). Most recently, Reinhard Kandera Bought $7,000 shares of Hookipa Pharma on Aug 22, 2023 for an estimated value of 5.04K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+19.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Reinhard Kandera's holdings
Insider Roles
CFO, Director
Roles that Reinhard Kandera holds in companies
Most Profitable Insider Trade
The most profitable trade made by Reinhard Kandera
Reinhard Kandera's Trading History
List of latest transactions for each holding click on a transaction to see Reinhard Kandera's performance on stock
You May Also Like
Reinhard Kandera insider profile FAQ
What is the percentage of profitable transactions made by Reinhard Kandera?
The percentage of profitable transactions made by Reinhard Kandera is 100%.
What is the average return per transaction made by Reinhard Kandera?
The average return per transaction made by Reinhard Kandera is 19.30%.
What stocks does Reinhard Kandera hold?
Reinhard Kandera holds: HOOK stocks.
What was Reinhard Kandera’s latest transaction?
Reinhard Kandera latest transaction was an Informative Buy of $5.04K.
What was Reinhard Kandera's most profitable transaction?
Reinhard Kandera’s most profitable transaction was an Informative Buy of HOOK stock on August 22, 2023. The return on the trade was 29.60%.
What is Reinhard Kandera's role in Hookipa Pharma?
Reinhard Kandera's role in Hookipa Pharma is CFO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.